home | contact | pubmed search | Keyword Search:
ImmuneDisease.com logo Patients & FamiliesHealthcare ProfessionalsGAMMAGARD

Continuing Education Courses

PI eTextbook

Therapeutics

Reimbursement Assistance

Calendar

News

Educational Materials

Educational Games

Important Safety Information

Prescribing Information

Sign Up Today

The Immune Disease eNewsletter gives you the latest updates.

Brought to you by Baxter
Primary Immunodeficiency
eTextbook

Treatment of Primary Immunodeficiency

These links provide a list of web sites about immune diseases that may be of interest to healthcare professionals. Baxter Healthcare Corporation does not possess editorial control over the content or the information on those other sites. As such, Baxter Healthcare Corporation and the compiler of the list make no representation as to the accuracy, completeness and any other aspect of the information contained in those sites.

Intravenous Immunoglobulin (IVIG)

History

  • Good RA. Historic Aspects of Intravenous Immunoglobulin Therapy.
    Cancer. 1991 Sep 15;68(6 Suppl):1415-21 (View Abstract)

Intravenous Immunoglobulin: Prevention and Treatment of Disease

Mechanisms of Action, Pharmacology and Clinical Uses

  • Schiff RI. Intravenous Gammaglobulin: Pharmacology, Clinical Uses and Mechanisms of Action. Pediatr Allergy Immunol. 1994 May;5(2):63-87 (View Citation)
  • Schiff RI. Intravenous Gammaglobulin, 2: Pharmacology, Clinical Uses and Mechanisms of Action. Pediatr Allergy Immunol. 1994 May;5(2):127-156 (View Citation)
  • Simon HU. IVIG-Mechanism of Action. Allergy. 2003 Jul;58(7):543-52 (View Abstract)

Risks Associated with the Use of IVIG

  • Pierce RL. Risks Associated With the Use of Intravenous Immunoglobulin. Transfus Med Rev. 2003 Oct;17(4):241-51 (View Abstract)

Other Treatment Options

  • Buckley R.H. et al. Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency. N Engl J Med. 1999 Feb 18;340(7):508-16 (View Abstract)
  • Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Gene therapy for immunodeficiency diseases. Semin Hematol. 2004 Oct;41(4):272-8. (View Abstract)
  • Haddad E et al. Long-Term Immune Reconstitution and Outcome After HLA-Nonidentical T-Cell-Depleted Bone Marrow Transplantation for Severe Combined Immunodeficiency: A European Retrospective Study of 116 Patients. Blood. 1998 May 15;91(10):3646-53 (View Abstract)
  • Kohn DB. Gene Therapy for Genetic Haematological Disorders and Immunodeficiencies.
    J Intern Med. 2001 Apr;249(4):379-90 (View Abstract)
  • Myers LA. Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.
    Blood. 2002 Feb 1;99(3):872-8 (View Abstract)

Study abstracts have been provided to assist you in selecting literature that may be of interest in your practice. As a professional courtesy, we will be happy to provide full text articles upon request. Please feel free to contact our Medical Affairs-Professional Services department toll-free at 1-866-4BIOSCI (424-6724).

top of page

This site is intended for use only by residents of the United States. Copyright 2005 Baxter Healthcare Corporation. All Rights Reserved